Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Diagnosis of Zollinger-Ellison syndrome in the era of PPIs, faulty gastrin assays, sensitive imaging and limited access to acid secretory testing.

Metz DC, Cadiot G, Poitras P, Ito T, Jensen RT.

Int J Endocr Oncol. 2017;4(4):167-185. doi: 10.2217/ije-2017-0018. Epub 2017 Oct 11.

PMID:
29326808
2.

Molecular imaging in neuroendocrine tumors: recent advances, controversies, unresolved issues, and roles in management.

Ito T, Jensen RT.

Curr Opin Endocrinol Diabetes Obes. 2017 Feb;24(1):15-24. doi: 10.1097/MED.0000000000000300.

3.

Utility of indium-111 octreotide to identify a cardiac metastasis of a carcinoid neoplasm.

Farooqui M, Rathore S, Ball T.

Proc (Bayl Univ Med Cent). 2016 Jan;29(1):76-8.

4.

False-positive (111)In-pentetreotide Uptake in Gastritis.

Usmani S, Alshammari A.

World J Nucl Med. 2013 May;12(2):76-8. doi: 10.4103/1450-1147.136699.

5.

An incidentally found inflamed uterine myoma causing low abdominal pain, using Tc-99m-tektrotyd single photon emission computed tomography-CT hybrid imaging.

Zandieh S, Sch├╝tz M, Bernt R, Zwerina J, Haller J.

Korean J Radiol. 2013 Sep-Oct;14(5):841-4. doi: 10.3348/kjr.2013.14.5.841. Epub 2013 Aug 30.

7.

High-grade KIT-negative sarcoma of the small bowel in a patient with chronic myeloid leukemia receiving long-term tyrosine kinase inhibitors.

Martz J, Jain S, Vahdat LT, Qin L, Mosquera JM, Antonescu CR, Popa EC.

J Clin Oncol. 2013 Apr 10;31(11):e181-5. doi: 10.1200/JCO.2012.42.7989. Epub 2013 Feb 25. No abstract available.

8.

Value of surgery in patients with negative imaging and sporadic Zollinger-Ellison syndrome.

Norton JA, Fraker DL, Alexander HR, Jensen RT.

Ann Surg. 2012 Sep;256(3):509-17. doi: 10.1097/SLA.0b013e318265f08d.

9.

Pancreatic endocrine tumors with major vascular abutment, involvement, or encasement and indication for resection.

Norton JA, Harris EJ, Chen Y, Visser BC, Poultsides GA, Kunz PC, Fisher GA, Jensen RT.

Arch Surg. 2011 Jun;146(6):724-32. doi: 10.1001/archsurg.2011.129.

10.

Imaging of gastroenteropancreatic neuroendocrine tumors.

Tan EH, Tan CH.

World J Clin Oncol. 2011 Jan 10;2(1):28-43. doi: 10.5306/wjco.v2.i1.28.

11.

Pitfalls in neuroendocrine tumor diagnosis.

Bajetta E, Platania M.

Rare Tumors. 2009 Dec 28;1(2):e32. doi: 10.4081/rt.2009.e32. No abstract available.

12.

Mechanism of acid hypersecretion post curative gastrinoma resection.

Ojeaburu JV, Ito T, Crafa P, Bordi C, Jensen RT.

Dig Dis Sci. 2011 Jan;56(1):139-54. doi: 10.1007/s10620-010-1234-1. Epub 2010 Aug 20.

13.

NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas.

Kulke MH, Anthony LB, Bushnell DL, de Herder WW, Goldsmith SJ, Klimstra DS, Marx SJ, Pasieka JL, Pommier RF, Yao JC, Jensen RT; North American Neuroendocrine Tumor Society (NANETS).

Pancreas. 2010 Aug;39(6):735-52. doi: 10.1097/MPA.0b013e3181ebb168.

14.

Inherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management, and controversies.

Jensen RT, Berna MJ, Bingham DB, Norton JA.

Cancer. 2008 Oct 1;113(7 Suppl):1807-43. doi: 10.1002/cncr.23648. Review.

15.

A "false positive" octreoscan in ileal Crohn's disease.

Fernandez A, Tabuenca O, Peteiro A.

World J Gastroenterol. 2008 Sep 14;14(34):5349-52.

16.

Comparison of surgical results in patients with advanced and limited disease with multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome.

Norton JA, Alexander HR, Fraker DL, Venzon DJ, Gibril F, Jensen RT.

Ann Surg. 2001 Oct;234(4):495-505; discussion 505-6.

Supplemental Content

Support Center